Catalyst Wire Dossier Catalyst Wire Dossier

BLUDIGO

INDIGOTINDISULFONATE SODIUM · Sagent Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BLUDIGO, covering 2022-07-08 to 2023-04-14. Get the full timeline:

Most recent: FDA Approved: BLUDIGO — Supplemental Application (Sagent Pharmaceuticals)

See pricing